Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
15.59
-0.58 (-3.59%)
Jul 11, 2025, 4:00 PM - Market closed

Tandem Diabetes Care Stock Forecast

Stock Price Forecast

The 13 analysts that cover Tandem Diabetes Care stock have a consensus rating of "Buy" and an average price target of $32.15, which forecasts a 106.22% increase in the stock price over the next year. The lowest target is $14 and the highest is $59.

Price Target: $32.15 (+106.22%)
Analyst Consensus: Buy
Target Low Average Median High
Price $14 $32.15 $24 $59
Change -10.20% +106.22% +53.94% +278.45%

Analyst Ratings

The average analyst rating for Tandem Diabetes Care stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Feb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy 544422
Buy 866544
Hold 256676
Sell 000000
Strong Sell 000001
Total 151516151313

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Citigroup
Citigroup
Strong Sell
Downgrades
$24$14
Strong Sell Downgrades $24$14 -10.20% Jul 9, 2025
Truist Securities
Truist Securities
Hold
Initiates
$24
Hold Initiates $24 +53.94% Jun 16, 2025
Citigroup
Citigroup
Hold
Maintains
$20$24
Hold Maintains $20$24 +53.94% May 22, 2025
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$58$59
Strong Buy Maintains $58$59 +278.45% May 1, 2025
Stifel
Stifel
Strong Buy
Maintains
$60$31
Strong Buy Maintains $60$31 +98.85% May 1, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
1.02B
from 940.20M
Increased by 8.91%
Revenue Next Year
1.14B
from 1.02B
Increased by 11.04%
EPS This Year
-1.44
from -1.47
EPS Next Year
-0.70
from -1.44
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
498.83M702.80M801.22M747.72M940.20M1.02B1.14B1.25B
Revenue Growth
37.68%40.89%14.00%-6.68%25.74%8.91%11.04%9.59%
EPS
-0.560.24-1.47-3.43-1.47-1.44-0.70-0.03
EPS Growth
--------
Forward PE
--------
No. Analysts
-----272720
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 1.1B1.3B1.4B
Avg 1.0B1.1B1.2B
Low 975.4M1.0B1.1B

Revenue Growth

Revenue Growth 20252026202720282029
High
14.5%
24.1%
23.6%
Avg
8.9%
11.0%
9.6%
Low
3.7%
1.5%
-2.4%

EPS Forecast

EPS 20252026202720282029
High -1.17-0.260.96
Avg -1.44-0.70-0.03
Low -1.65-1.38-0.74

EPS Growth

EPS Growth 20252026202720282029
High ---
Avg ---
Low ---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.